Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Aug 16;6(10):1933-1940.
doi: 10.1002/ccr3.1739. eCollection 2018 Oct.

Case report: An infantile lethal form of Albright hereditary osteodystrophy due to a GNAS mutation

Affiliations
Case Reports

Case report: An infantile lethal form of Albright hereditary osteodystrophy due to a GNAS mutation

Valérie Leclercq et al. Clin Case Rep. .

Abstract

Germline loss-of-function GNAS mutations are associated with multiple phenotypes, depending on the parental origin of the mutant allele. Here, we describe an infantile lethal form of atypical pseudohypoparathyroidism type 1a or 1c with severe Albright's hereditary osteodystrophy phenotype, underlying the extremely variable expressivity of this syndrome.

Keywords: Albright's hereditary osteodystrophy; GNAS mutation; inactivating PTH/PTHrP signaling disorders; pseudohypoparathyroidism; severe phenotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The growth curves of our patient illustrate the severe failure to thrive, which is more pronounced for the height (A) than for the weight (B) and the head circumference (C). The last two parameters tend to normalize with time, contrary to the height. This disharmonic evolution leads to an increasing body mass index (D), which reaches values of morbid obesity after the age of 2 y
Figure 2
Figure 2
Proband's hand X‐rays at 1.5 mo (A) and 22 mo (B), showing brachymetacarpy and brachydactyly, which are more obvious with age. At 22 mo, the bone age was estimated to be delayed by 1 y. Proband's knee X‐rays at 1.5 mo (C), showing no distinctive sign of acroscyphodysplasia
Figure 3
Figure 3
Proband's clinical phenotype: (A) At birth, he had a short stature and moderate facial dysmorphism (short nose with anteverted nostrils, mandibular hypoplasia, and full cheeks). At 16 mo (B1‐2) and at 27 mo (C1‐2, D, E), he showed severe growth retardation, obesity, facial dysmorphism (round face, extremely short nose, prominent tongue, full cheeks), short neck, brachydactyly, and edema of the hands and feet
Figure 4
Figure 4
The c.691C>T, p.Arg231Cys mutation in the GNAS gene (NM_000516.4) was detected in the patient's lymphocytes (A), but was absent in the maternal (B) and paternal (C) blood samples
Figure 5
Figure 5
The arginine concerned by the c.691C>T, p.Arg231Cys mutation is highly conserved through the species in the amino acid sequence of the G alpha subunit (reference of the human protein sequence: NP_000507.1)

References

    1. Vlaeminck‐Guillem V, Wémeau JL. Pseudohypoparathyroïdies: hétérogénéité clinique et moléculaire. Med Sci. 1999;15:1244‐1251.
    1. Lemos MC, Thakker RV. GNAS mutations in pseudohypoparathyroidism type 1a and related disorders. Hum Mutat. 2015;36(1):11‐19. - PMC - PubMed
    1. Thiele S, Mantovani G, Barlier A, et al. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol. 2016;175(6):1‐17. - PubMed
    1. Ahrens W, Hiort O, Staedt P, et al. Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab. 2001;86:4630‐4634. - PubMed
    1. Mitsui T, Kim OH, Hall CM, et al. Acroscyphodysplasia as a phenotypic variation of pseudohypoparathyroidism and acrodysostosis type 2. Am J Med Genet Part A. 2014;164A:2529‐2534. - PubMed

Publication types